NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.
Mar 29, 2023
06:13
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.
NEJM Interviews